DDIT4 and gastric cancer: Du et al. found that downregulation of DDIT4 results in chemical sensitivity and proliferative suppression, indicating that the p53 and MAPK signaling pathways are activated, revealing that downregulation of DDIT4 suppresses gastric cancer tumor development [50].